scholarly article | Q13442814 |
P2093 | author name string | C A Maggi | |
S Giuliani | |||
C Valenti | |||
M Tramontana | |||
C Cialdai | |||
P2860 | cites work | Tumour necrosis factor-alpha mediates carrageenin-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints | Q78048345 |
International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences | Q28237006 | ||
Human tissue kallikrein | Q28293675 | ||
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 | ||
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence | Q33295110 | ||
Identification and functional importance of plasma kallikrein in the synovial fluids of patients with rheumatoid, psoriatic, and osteoarthritis | Q33567265 | ||
Arthritis and pain. Future targets to control osteoarthritis pain | Q34636446 | ||
Bradykinin initiates cytokine-mediated inflammatory hyperalgesia | Q34729234 | ||
Glucocorticoids in rheumatoid arthritis: effects on erosions and bone | Q34735524 | ||
Studies on kallikrein: failure of some anti-inflammatory drugs to affect release of kinin | Q34795018 | ||
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia | Q35871035 | ||
An overview of the effects of annexin 1 on cells involved in the inflammatory process | Q36165863 | ||
Regulation of angiogenesis by the kallikrein-kinin system | Q36536347 | ||
Intracellular signaling in primary sensory neurons and persistent pain | Q37144214 | ||
Knee osteoarthritis: a role for bradykinin? | Q37267272 | ||
Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression | Q40165573 | ||
Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease | Q40498652 | ||
Characterization of bradykinin receptors in a human osteoblastic cell line | Q40764725 | ||
The assay of glandular kallikrein and prekallikrein in human mixed saliva | Q41294194 | ||
Bradykinin-induced neurogenic migration of neutrophils into the rat knee joint | Q41724745 | ||
Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation | Q41866780 | ||
Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy | Q41966399 | ||
Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia | Q41975774 | ||
Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis | Q42450258 | ||
Mechanism of bradykinin‐induced plasma extravasation in the rat knee joint | Q42479233 | ||
Mechanisms of prostanoid synthesis in human synovial cells: cytokine-peptide synergism | Q42526278 | ||
Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin 1, bradykinin, and other agonists | Q42835304 | ||
Modeling corticosteroid effects in a rat model of rheumatoid arthritis II: mechanistic pharmacodynamic model for dexamethasone effects in Lewis rats with collagen-induced arthritis | Q43249855 | ||
Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor an | Q43278309 | ||
Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint | Q44153399 | ||
MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization. | Q46409814 | ||
Glucocorticoids suppress transcriptional up-regulation of bradykinin receptors in a murine in vitro model of chronic airway inflammation | Q46442628 | ||
MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs | Q46606928 | ||
The activity of fine afferent nerve fibres of the rat knee joint and their modulation by inflammatory mediators. | Q46662003 | ||
Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI. | Q46674813 | ||
Guide to Receptors and Channels (GRAC), 4th Edition | Q56639335 | ||
Influence of a long-acting bradykinin antagonist, Hoe 140, on some acute inflammatory reactions in the rat | Q68183701 | ||
Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikreins | Q71351369 | ||
Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation | Q71771048 | ||
Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis | Q77993370 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dexamethasone | Q422252 |
P304 | page(s) | 1616-1627 | |
P577 | publication date | 2010-12-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Anti-inflammatory synergy of MEN16132, a kinin B(2) receptor antagonist, and dexamethasone in carrageenan-induced knee joint arthritis in rats | |
P478 | volume | 161 |
Q34395915 | Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation |
Q39448953 | Bradykinin enhances Sindbis virus infection in human brain microvascular endothelial cells. |
Q41848003 | Fasitibant chloride, a kinin B₂ receptor antagonist, and dexamethasone interact to inhibit carrageenan-induced inflammatory arthritis in rats |
Q61450662 | Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E2 release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes |
Q47987127 | P2X3 and P2X2/3 Receptors Play a Crucial Role in Articular Hyperalgesia Development Through Inflammatory Mechanisms in the Knee Joint Experimental Synovitis |
Q36160155 | Photobiomodulation therapy in the modulation of inflammatory mediators and bradykinin receptors in an experimental model of acute osteoarthritis |
Q91461179 | Sequestration of artemin reduces inflammation-induced activation and sensitization of bone marrow nociceptors in a rodent model of carrageenan-induced inflammatory bone pain |
Search more.